Futura Medical plc (LON:FUM – Get Free Report) shares were up 11.8% on Tuesday . The stock traded as high as GBX 14.98 ($0.19) and last traded at GBX 14.98 ($0.19). Approximately 343,060 shares were traded during trading, a decline of 60% from the average daily volume of 864,320 shares. The stock had previously closed at GBX 13.40 ($0.17).
Futura Medical Stock Down 3.6 %
The company has a market cap of £41.58 million, a PE ratio of -1,375.00 and a beta of 1.25. The company’s fifty day moving average is GBX 28.84 and its 200-day moving average is GBX 32.86.
About Futura Medical
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Featured Articles
- Five stocks we like better than Futura Medical
- The 3 Best Fintech Stocks to Buy Now
- PayPal: Time to Strike With Shares Down Double Digits?
- The How and Why of Investing in Gold Stocks
- Lattice Semiconductor’s Market Reset Is Over: The Rebound Begins
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
